Equate Pain Relieving Patches Patch
FDA Recall NDC 79903-106
FDA Enforcement Report: View Recall Date, Reasons, and Safety Status
Active & Historical Enforcement Reports
The FDA has identified 1 recorded enforcement report(s) associated with Equate Pain Relieving Patches (NDC 79903-106). A significant event, classified as Class II, was initiated on Oct 24, 2024 by Walmart, Inc. The reported reason for this action was: "cGMP Deviations"
This specific recall has a current status of TERMINATED, indicating that the FDA considers the recall process finished or the product successfully recovered.
This specific recall has a current status of TERMINATED, indicating that the FDA considers the recall process finished or the product successfully recovered.
Reported Recall Events
Class II Terminated
cGMP Deviations
Oct 24, 2024
Dec 04, 2024
1,101,600 patches
Recall Profile & Regulatory Data
Event ID
95595
Classification
Class II
Enforcement Status
Terminated
Recalling Firm
Unexo Life Sciences Private Limited
Voluntary / Mandated
Voluntary: Firm initiated
Distribution Pattern
Nationwide in the US
Termination Date
Sep 16, 2025
Product Description
EQUATE MAXIMUM STRENGTH LIDOCAINE PAIN RELIEVING PATCH Lidocaine 4% Topical Anesthetic, 6 patches per box PATCHES, LIDOCAINE 4%, Distributed by: Walmart Inc., Bentonville, AR 72716 NDC 79903-106-06
Batch or Lot Expiration Information
Lot# UPC 6 81131 07127 7
Affected Packages Involved in this Recall
79903-106-06Product
About FDA Recall Enforcement Reports
FDA recall data documents classified recall actions associated with a product. Most recalls are limited to specific lots, batches, or package configurations rather than every unit of a drug.
If a recall is listed for an NDC, review the affected lot information and package details carefully. Patients and healthcare professionals should confirm whether a specific product in hand matches the lot or package information before assuming it is affected.
